 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- ||| betamethasone sodium phosphate (SURF-200) / Harrow Health
Trial completion, Adverse events: Research Study To See How Well An Eye Drop (SURF-200) Works, What Side Effects There Are, And To Compare It With Vehicle In Subjects With An Episodic Flare-Up of Dry Eye Disease (clinicaltrials.gov) - Nov 14, 2022
P2, N=139, Completed, Sponsor: Surface Pharmaceuticals, Inc.
Active, not recruiting --> Completed
- || betamethasone sodium phosphate (SURF-200) / Harrow Health
Enrollment closed, Trial completion date, Trial primary completion date, Adverse events: Research Study To See How Well An Eye Drop (SURF-200) Works, What Side Effects There Are, And To Compare It With Vehicle In Subjects With An Episodic Flare-Up of Dry Eye Disease (clinicaltrials.gov) - Aug 10, 2022
P2, N=120, Active, not recruiting, Sponsor: Surface Pharmaceuticals, Inc.
Active, not recruiting --> Completed Recruiting --> Active, not recruiting | Trial completion date: Mar 2023 --> Oct 2022 | Trial primary completion date: Jan 2023 --> Oct 2022
- || betamethasone sodium phosphate (SURF-200) / Harrow Health
Trial completion date, Trial primary completion date, Adverse events: Research Study To See How Well An Eye Drop (SURF-200) Works, What Side Effects There Are, And To Compare It With Vehicle In Subjects With An Episodic Flare-Up of Dry Eye Disease (clinicaltrials.gov) - Aug 18, 2021
P2, N=120, Recruiting, Sponsor: Surface Pharmaceuticals, Inc.
Recruiting --> Active, not recruiting | Trial completion date: Mar 2023 --> Oct 2022 | Trial primary completion date: Jan 2023 --> Oct 2022 Trial completion date: Aug 2021 --> Mar 2023 | Trial primary completion date: Jun 2021 --> Jan 2023
- |||| betamethasone sodium phosphate (SURF-200) / Harrow Health
New P2 trial, Adverse events: Research Study To See How Well An Eye Drop (SURF-200) Works, What Side Effects There Are, And To Compare It With Vehicle In Subjects With An Episodic Flare-Up of Dry Eye Disease (clinicaltrials.gov) - Feb 2, 2021
P2, N=120, Recruiting, Sponsor: Surface Pharmaceuticals, Inc.